Cargando…

Reply to ‘Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10’

Detalles Bibliográficos
Autores principales:	Nieto Guevara, Javier, Izurieta, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560905/ https://www.ncbi.nlm.nih.gov/pubmed/32643508 http://dx.doi.org/10.1080/21645515.2020.1784654

Ejemplares similares

Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10
por: Camacho Moreno, Germán, et al.
Publicado: (2020)

Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease
por: Izurieta, Patricia, et al.
Publicado: (2021)

Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
por: Bennett, Julia C., et al.
Publicado: (2021)

Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction
por: Gladstone, Rebecca A., et al.
Publicado: (2015)

Invasive pneumococcal disease burden in hospitalized adults in Bogota, Colombia
por: Narváez, Paula O., et al.
Publicado: (2021)

Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi
por: Kirolos, Amir, et al.
Publicado: (2023)

Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan
por: Nisar, Muhammad Imran, et al.
Publicado: (2022)

COVID-19 spread, detection, and dynamics in Bogota, Colombia
por: Laajaj, Rachid, et al.
Publicado: (2021)

A Streptococcus pneumoniae lineage usually associated with pneumococcal conjugate vaccine (PCV) serotypes is the most common cause of serotype 35B invasive disease in South Africa, following routine use of PCV
por: Ndlangisa, Kedibone M., et al.
Publicado: (2022)

Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain
por: Morales, María, et al.
Publicado: (2018)

Genomic Characteristics of Invasive Streptococcus pneumoniae Serotype 1 in New Caledonia Prior to the Introduction of PCV13
por: Hanachi, Mariem, et al.
Publicado: (2020)

Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era
por: Izquierdo, C., et al.
Publicado: (2020)

Decrease in Hospitalizations for Pneumonia in Children under Five Years of Age in an Indian Reservation in Panama after the Introduction of the Heptavalent Pneumococcal Conjugate Vaccine (PCV7)
por: Nieto Guevara, Javier, et al.
Publicado: (2013)

Invasive Pneumococcal Disease Characterization in Adults and Subgroups aged < 60 years and ≥ 60 years in Bogota, Colombia
por: Castro, Aura Lucia Leal, et al.
Publicado: (2022)

Predicting Hospital Demand During the COVID-19 Outbreak in Bogotá, Colombia
por: Rivera-Rodriguez, Claudia, et al.
Publicado: (2020)

1180. Comparing Changes in Pneumococcal Meningitis Incidence to all Invasive Pneumococcal Disease Following Introduction of PCV10 and PCV13: The PSERENADE Project
por: Yang, Yangyupei, et al.
Publicado: (2021)

Changes in the incidence of acute bacterial meningitis caused by Streptococcus pneumoniae and the implications of serotype replacement in children in Colombia after mass vaccination with PCV10
por: Farfán-Albarracín, Juan David, et al.
Publicado: (2022)

Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009–June 2015
por: Regev-Yochay, Gili, et al.
Publicado: (2018)

Pediatric Invasive Pneumococcal Disease Three Years after PCV13 Introduction in the National Immunization Plan—The Continued Importance of Serotype 3
por: Silva-Costa, Catarina, et al.
Publicado: (2021)

Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants”
por: Gómez, Jorge A., et al.
Publicado: (2021)

Emergency department characteristics and capabilities in Bogotá, Colombia
por: Bustos, Yury, et al.
Publicado: (2015)

Reduction of chronic malnutrition for infants in Bogotá, Colombia
por: Castro Prieto, Paula Andrea, et al.
Publicado: (2021)

Dataset of traffic accidents in motorcyclists in Bogotá, Colombia
por: Ospina-Mateus, Holman, et al.
Publicado: (2022)

The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination
por: Slotved, Hans-Christian, et al.
Publicado: (2016)

Impact of PCV13 on Serotype 3 Invasive Pneumococcal Disease and Nasopharyngeal Carriage in Massachusetts’ Children
por: Lapidot, Rotem, et al.
Publicado: (2017)

Pneumococcal meningitis trends after pneumococcal conjugate vaccine introduction in Colombia: An interrupted time-series analysis
por: Caceres, Diana C., et al.
Publicado: (2018)

Decline in Vaccine-Type Streptococcus pneumoniae Serotypes Following Pneumococcal Conjugate Vaccine Introduction in Madagascar
por: Raboba, Julia L, et al.
Publicado: (2021)

Serotype Distribution and Antimicrobial Sensitivity Profile of Streptococcus pneumoniae Carried in Healthy Toddlers before PCV13 Introduction in Niamey, Niger
por: Ousmane, Sani, et al.
Publicado: (2017)

2703. Pneumococcal Carriage of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Non-PCV13 Serotypes among Greek Children Vaccinated with PCV13 in a 3 + 1 Schedule During the First 6 years after the Fourth Dose of PCV13
por: Syrogiannopoulos, George A, et al.
Publicado: (2019)

Streptococcus mitis Expressing Pneumococcal Serotype 1 Capsule
por: Lessa, Fernanda C., et al.
Publicado: (2018)

Population genomics of pneumococcal carriage in Massachusetts children following introduction of PCV-13
por: Mitchell, Patrick K., et al.
Publicado: (2019)

Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in Indonesia
por: Suwantika, Auliya A., et al.
Publicado: (2020)

Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project
por: Garcia Quesada, Maria, et al.
Publicado: (2021)

Population structure, epidemiology and antibiotic resistance patterns of Streptococcus pneumoniae serotype 5: prior to PCV-13 vaccine introduction in Eastern Gambia
por: Ashu, Eta E., et al.
Publicado: (2016)

The dynamic change of serotype distribution and antimicrobial resistance of pneumococcal isolates since PCV13 administration and COVID-19 control in Urumqi, China
por: Guo, Meng-Yang, et al.
Publicado: (2023)

Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia
por: Sime, Wondewosen Tsegaye, et al.
Publicado: (2019)

High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi
por: Swarthout, Todd D., et al.
Publicado: (2020)

Astonishing diversity—the medicinal plant markets of Bogotá, Colombia
por: Bussmann, Rainer W., et al.
Publicado: (2018)

Executive function in down syndrome children in Bogotá, Colombia
por: Manrique-Niño, Julián, et al.
Publicado: (2020)

Correction to: Reduction of chronic malnutrition for infants in Bogotá, Colombia
por: Castro Prieto, Paula Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_osvjkm0jsc571dansijocnpou1